Compounds > organophosphonates
Page last updated: 2024-09-05

organophosphonates and Delayed Effects, Prenatal Exposure

organophosphonates has been researched along with Delayed Effects, Prenatal Exposure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amani-Bosse, C; Arrivé, E; Blanche, S; Dabis, F; Ekouévi, DK; Gray, G; Hirt, D; Kone, M; Leang, SK; McIntyre, J; Nerrienet, E; Rey, E; Tréluyer, JM; Urien, S1
Arrivé, E; Avit, D; Blanche, S; Coffié, P; Dabis, F; Ekouévi, DK; Hirt, D; Lalsab, S; Leang, SK; McIntyre, J; Nerrienet, E; Rey, E; Tréluyer, JM; Urien, S1

Trials

1 trial(s) available for organophosphonates and Delayed Effects, Prenatal Exposure

ArticleYear
Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).
    Clinical pharmacology and therapeutics, 2009, Volume: 85, Issue:2

    Topics: Adenine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Maternal-Fetal Exchange; Organophosphonates; Population Groups; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Tenofovir

2009

Other Studies

1 other study(ies) available for organophosphonates and Delayed Effects, Prenatal Exposure

ArticleYear
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Adenine; Anti-HIV Agents; Area Under Curve; Clinical Trials as Topic; Deoxycytidine; Emtricitabine; Female; Half-Life; HIV Infections; HIV-1; Humans; Infant, Newborn; Maternal-Fetal Exchange; Organophosphonates; Population Groups; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Tenofovir

2009